Vés al contingut

Entrevistes a Begoña Cánovas, postdoc del laboratori de Senyalització i Cicle Cel·lular de l'IRB Barcelona

L'IRB Barcelona als mitjans
30 maig 18

Images

Participants

Contact

Imatge
Communication Officer
Tel.+34 93 40 37255

La Voz de Galicia, TV3 i 8TV, entre altres mitjans de comunicació, han entrevistat a Begoña Cánovas, primera autora del darrer estudi de l'IRB Barcelona publicat a la revista Cancer Cell i que ha identificat la proteïna p38 com un salvavides que fan servir les cèl·lules tumorals per evitar l'excessiu dany en el seu ADN, el que les sentenciaria a morir.

Enllaç a TV3

Enllaç a 8TV

Adjunt:

About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 28 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).